UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan.
暂无分享,去创建一个
J. Panetta | C. Rodríguez-Galindo | L. McGregor | W. Furman | A. Gajjar | C. Stewart | Tiebin Liu | C. Billups | Charles H. Fraga | M. O'Shaughnessy | S. Throm | T. Owens | Thandranese S. Owens